HealthHighSingle-sourceAccelerating
7.1
NHS trust admits 300+ women harmed by needless breast removals
BBC NewsLO·GB·2 days ago
HealthSingle-sourceMedium
5.2
UK NHS approves Enhertu for HER2-low advanced breast cancer after price deal
England's NHS will fund Enhertu for ~1,000 women/year with HER2-low advanced breast cancer after a pricing agreement, extending life for incurable patients. The deal resolves prior cost-effectiveness hurdles, marking a notable access expansion for a targeted therapy. Impact is primarily clinical and fiscal for the UK health system.
Score Breakdown
Mosaic Score5.2
Confidence0.9
Significance0.5
Source credibility0.3
Intelligence Tags
Locations
England
Entities
country
Related signals
8 foundHealthNotableCorroborating
5.6
Brazil SUS oncology hospitalizations rise, disparities hit minorities
Poder360·BR·about 14 hours ago
HealthNotablePartialDeveloping
5.3
Bosnian Oncology Patients Face Persistent Chemotherapy Drug Shortages
N1 BosniaLO·BA·about 14 hours ago
PoliticsNotableSingle-source
5.2
Former Labour deputy leader Tom Watson joins Palantir amid UK government contract pressure
Guardian WorldLO·GB·3 days ago
HealthNotableSingle-source
5.2
EU Panel Recommends AstraZeneca's Enhertu for Early Breast Cancer
Dagens IndustriLO·SE·3 days ago
HealthNotableSingle-sourceDeveloping
5.2
NHS trust admits 20 women had unnecessary mastectomies in cancer care failure
BBC NewsLO·GB·3 days ago
HealthNotableSingle-source
5.1
Severe mental illness linked to 15-20 year mortality gap from preventable diseases
Guardian WorldLO·GB·about 11 hours ago
HealthNotableSingle-source
4.9
Roche's Lunsumio combination meets primary endpoint in late-stage blood cancer trial
Die PresseLO·CH·3 days ago